X-ray contrast compositions containing a barium salt and film-forming materials

Claim 1

Am x-ray contrast composition designed for depositing a thin, flexible film membrane onto the mucosal lining of the nutrient absorbing inner surface of the intestine to form a barrier between the nutrient absorbing inner surface and the content of the intestine, the flexible film membrane to remain bound to the mucosal lining until eliminated by normal cell turnover comprising based on w/w: (a) of from about 0.001 to about 25% of a polymeric material capable of forming a film membrane on the gastrointestinal tract in the pH range of from about 5 to about 8, said the polymeric material being selected from the group consisting of: dermatan sulfate, hepatosulfate, hyabromic acid, heparin, chitin, and ethylene oxide: (b) of from about 0.1 to about 20% of a divalent cation to potentiate the binding of the flexible film membrane to the mucosal lining selected from the group consisting of Ca ++ , Mg ++ , Zn ++ and Ba ++ ; (c) of from about 5 to about 95% of a barium salt in a liquid pharmaceutically acceptable carrier comprising a surfactant selected from the group consisting of cetyltrimethyl ammonium bromide, dodecyl ammonium bromide, sodium lauryl sulfate: sodium heptadecyl sulfate, alkyl benzene sulfonic acid, carboxylic esters, carboxylic amides, ethoxylated alkylphenols, ethoxylated aliphatic alcohols, polyoxyethylene alkyl ethers polyoxyethylene sorbitan fatty acid esters; and zwitterionic surfactants.

Claim 4

A method of carrying out x-ray examination of the gastrointestinal tract of a patient, said method comprises the oral or rectal administration to the patient an x-ray contrast composition designed for depositing a thin, flexible film membrane onto the mucosal lining of the nutrient absorbing inner surface of the intestine of a patient to form a barrier between said nutrient absorbing inner surface and the content of said intestine, said flexible film membrane to remain bound to said mucosal lining until eliminated by normal cell turnover comprising based on w/w: (a) of from about 0.001 to about 25% of a polymeric material capable of forming a film membrane on the gastrointestinal tract in the pH range of from about 5 to about 8, said the polymeric material being selected from the group consisting of: dermatan sulfate. hepatosulfate, hyabromic acid. heparin, chitin, and ethylene oxide; (b) of from about 0.1 to about 20% of a divalent cation to potentiate the binding of the flexible film membrane to the mucosal lining selected from the group consisting of Ca ++ , Mg ++ , Zn ++ and Ba ++ ; (c) of from about 5 to about 95% of a barium salt in a liquid pharmaceutically acceptable carrier comprising a surfactant selected from the group consisting of cetyltrimethyl ammonium bromide, dodecyl ammonium bromide, sodium lauryl sulfate, sodium heptadecyl sulfate, alkyl benzene sulfonic acid, carboxylic esters, carboxylic amides, ethoxylated alkylphenols, ethoxylated aliphatic alcohols, polyoxyethylene alkyl ethers polyoxyethylene sorbitan fatty acid esters; and zwitterionic surfactants; and exposing the gastrointestinal tract containing said x-ray contrast composition to x-rays to form an x-ray image pattern corresponding to the presence of said x-ray contrast composition, and visualizing said image pattern.

Claim 5

A method of carrying out x-ray examination of the gastrointestinal tract of a patient, said method comprises the oral or rectal administration to the patient an x-ray contrast composition designed for depositing a thin, flexible film membrane onto the mucosal lining of the nutrient absorbing inner surface of the intestine of a patient to form a barrier between said nutrient absorbing inner surface and the content of said intestine, said flexible film membrane to remain bound to said mucosal lining until eliminated by normal cell turnover comprising based on w/w: (a) of from about 0.001 to about 25% of a polymeric material capable of forming a film membrane on the gastrointestinal tract in the pH range of from about 5 to about 8, said the polymeric material being selected from the group consisting of: dermatan sulfate. hepatosulfate, hyabromic acid. heparin, chitin, and ethylene oxide; (b) of from about 0.1 to about 20% of a divalent cation to potentiate the binding of the flexible film membrane to the mucosal lining selected from the group consisting of Ca ++ , Mg ++ , Zn ++ and Ba ++ ; (c) of from about 5 to about 95% of a barium salt in a liquid pharmaceutically acceptable carrier comprising a surfactant selected from the group consisting of cetyltrimethyl ammonium bromide, dodecyl ammonium bromide, sodium lauryl sulfate, sodium heptadecyl sulfate, alkyl benzene sulfonic acid, carboxylic esters, carboxylic amides, ethoxylated alkylphenols, ethoxylated aliphatic alcohols, polyoxyethylene alkyl ethers polyoxyethylene sorbitan fatty acid esters; and zwitterionic surfactants; and exposing the gastrointestinal tract containing said x-ray contrast composition to x-rays to form an x-ray image pattern corresponding to the presence of said x-ray contrast composition, and visualizing said image pattern.